Iovance Biotherapeutics, Inc. (0JDK.L)

USD 2.8

(-7.85%)

Inventory Summary of Iovance Biotherapeutics, Inc.

  • Iovance Biotherapeutics, Inc.'s latest annual inventory in 2023 was 10.37 Million USD , down 0.0% from previous year.
  • Iovance Biotherapeutics, Inc.'s latest quarterly inventory in 2024 Q1 was 17.61 Million USD , up 69.85% from previous quarter.
  • Iovance Biotherapeutics, Inc. reported annual inventory of - USD in 2022, down 0.0% from previous year.
  • Iovance Biotherapeutics, Inc. reported annual inventory of - USD in 2021, down 0.0% from previous year.
  • Iovance Biotherapeutics, Inc. reported quarterly inventory of 27.85 Million USD for 2024 Q2, up 58.11% from previous quarter.
  • Iovance Biotherapeutics, Inc. reported quarterly inventory of 9.19 Million USD for 2023 Q3, down -5.4% from previous quarter.

Annual Inventory Chart of Iovance Biotherapeutics, Inc. (2023 - 2012)

Historical Annual Inventory of Iovance Biotherapeutics, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 10.37 Million USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of Iovance Biotherapeutics, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD 13.739%
Agios Pharmaceuticals, Inc. 19.07 Million USD 45.628%
Amicus Therapeutics, Inc. 59.69 Million USD 82.625%
Atara Biotherapeutics, Inc. 9.7 Million USD -6.862%
bluebird bio, Inc. 22.91 Million USD 54.745%
Cara Therapeutics, Inc. 2.82 Million USD -267.671%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 97.312%
Myriad Genetics, Inc. 20.1 Million USD 48.398%
Neurocrine Biosciences, Inc. 38.3 Million USD 72.919%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 86.601%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.875%
Waters Corporation 516.23 Million USD 97.991%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.796%
Biogen Inc. 2.52 Billion USD 99.59%
Nektar Therapeutics 16.1 Million USD 35.582%
Perrigo Company plc 1.14 Billion USD 99.091%
Dynavax Technologies Corporation 53.29 Million USD 80.537%
Illumina, Inc. 587 Million USD 98.233%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 75.369%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 99.063%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD 5.692%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.598%
Esperion Therapeutics, Inc. 65.62 Million USD 84.195%
FibroGen, Inc. 41.56 Million USD 75.046%
Agilent Technologies, Inc. 1.03 Billion USD 98.994%
OPKO Health, Inc. 65.69 Million USD 84.212%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 88.365%
Exelixis, Inc. 17.32 Million USD 40.126%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.595%
Axsome Therapeutics, Inc. 15.13 Million USD 31.47%
Abeona Therapeutics Inc. -2.44 Million USD 524.386%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 98.596%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 63.511%
Sarepta Therapeutics, Inc. 322.85 Million USD 96.787%
Corcept Therapeutics Incorporated 7.73 Million USD -34.179%
Halozyme Therapeutics, Inc. 127.6 Million USD 91.872%
Blueprint Medicines Corporation 21.22 Million USD 51.128%
Insmed Incorporated 83.24 Million USD 87.541%
TG Therapeutics, Inc. 39.82 Million USD 73.955%
Incyte Corporation 62.97 Million USD 83.529%
Emergent BioSolutions Inc. 328.9 Million USD 96.846%